PVD News

Click on any of the articles below for the latest from the PVD community.

Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia

March 30, 2023


BACKGROUND Approximately 20% of patients with chronic limb-threatening ischemia have no revascularization options, leading to above-ankle amputation. Transcatheter arterialization of the deep veins is a percutaneous approach that creates an artery-to-vein connection for delivery of oxygenated blood by means of the venous system to the ischemic foot to prevent amputation.

Surgery vs. endovascular intervention for critical limb ischemia in the BEST-CLI trial

November 21, 2022


We spoke with BEST-CLI trial principal investigators Alik Farber, MD, from Boston Medical Center; Matthew Menard, MD, from Brigham and Women's Hospital; and Ken Rosenfield, MD, from Mass General Hospital during the American Heart Association’s Scientific Sessions 2022 conference in Chicago The trial looked at endovascular versus bypass surgery in patients with critical limb ischemia (CLI) to see which treatment option is better.

First Round of Late-Breaking Clinical Trial Results Announced at VIVA22

November 1, 2022


The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of three Late-Breaking Clinical Trials session at the VIVA22 conference, hosted at Wynn Las Vegas.

Disrupt the curve of amputations

September 29, 2022


Diabetes is the single greatest factor in amputations—more than 60 percent of non-traumatic lower limb amputations happen in the diabetes population. An individual who has had an amputation has a worse chance of five-year survival than someone with coronary artery disease, breast cancer, and colorectal cancer. Amputations in the United States are also substantially more prevalent among people of color.

Late-breaking Clinical Trial presentations announced for The VEINS and VIVA Conference

September 14, 2022


Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INterventional Strategies) and VIVA (Vascular InterVentional Advances) Annual Conference have been announced. Leading physicians and researchers will present results from 21 clinical trials, from Monday, October 31, to Wednesday, November 2, at Wynn Las Vegas.

September is PAD Awareness Month

September 1, 2022


September is Peripheral Artery Disease (PAD) Awareness Month! PAD is a chronic circulatory condition, which if left untreated can result in unnecessary limb amputations. PAD affects nearly 20 million Americans, and an estimated 200,000 of them – disproportionately from minorities communities – suffer avoidable amputations every year.

A Study of the Peripheral Vessels in Patients With Type 2 Diabetes Mellitus With or Without Foot Involvement

August 29, 2022


Abstract: Peripheral vascular disease (PVD) is chronic limb ischemia caused by atherosclerosis of the peripheral arteries. Diabetes mellitus (DM) is a risk factor for this disease. The probability of a diabetic foot ulcer (DFU) is higher in a patient with DM and PVD than in a patient without DM. Ankle-brachial-pressure index (ABPI) allows the measurement of blood flow towards the distal extremities, which could help timely diagnosis, initiate brief therapy, and minimize the risk of critical limb ischemia and loss. This study aims to determine the prevalence of peripheral vascular diseas...

Walking for Peripheral Artery Disease: No Pain, No Gain

August 1, 2022


Walking at high intensity improved leg function among people with peripheral artery disease (PAD), according to research published in the Journal of the American Heart Association. “We were surprised by the results because walking for exercise at a pace that induces pain in the legs among people with PAD has been thought to be damaging to leg muscles,” said senior study author...

Philips Announces Three-Year Results From Its Tack Optimized Balloon Angioplasty (TOBA) II Below-The-Knee (BTK) Clinical Trial

June 14, 2022


Royal Philips announced the latest results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial, demonstrating that the Philips endovascular system – Tack (4F) – provides a sustained treatment effect and positive impact on quality of life for patients with critical limb ischemia (CLI), a severe stage of peripheral arterial disease (PAD), out to three years of clinical follow-up.

Routine IVUS in Peripheral Interventions Supported by Small RCT

March 9, 2022


Compared with angiography alone, adding IVUS imaging to femoropopliteal artery interventions with drug-coated balloons (DCBs) results in less binary restenosis at 1 year, according to results from a single-center RCT. Yet the benefit wasn’t seen for procedures involving plain old balloon angioplasty (POBA) or stenting.


Educational Awareness Solutions
7 Hollyhock Road, Wilton, CT 06897
+1 (203) 604-1850

The PVD Channel is intended for healthcare professionals, and the material provided therein is not a substitute for professional medical advice.

All material on this website may not be published, broadcast, rewritten, or redistributed in any form without prior authorization.

Need technical assistance? Email info@thepvdchannel.com